For the year ending 2025-12-31, PRME has $342,733K in assets. $221,865K in debts. $63,032K in cash and cash equivalents.
| Balance Sheets | 2025-12-31 | |||
|---|---|---|---|---|
| Cash and cash equivalents | 63,032 | |||
| Short-term investments-Nonrelated Party | 114,648 | |||
| Short-term investments-Related Party | 0 | |||
| Prepaid expenses | 2,939 | |||
| Other current assets | 674 | |||
| Total current assets | 181,293 | |||
| Property and equipment, net | 20,572 | |||
| Operating lease right-of-use assets | 126,177 | |||
| Restricted cash | 13,691 | |||
| Other assets | 1,000 | |||
| Total assets | 342,733 | |||
| Accounts payable | 8,887 | |||
| Accrued expenses and other current liabilities | 12,600 | |||
| Deferred revenue related party | 7,824 | |||
| Operating lease liability | 8,137 | |||
| Total current liabilities | 37,448 | |||
| Deferred revenue, net of current related party | 58,127 | |||
| Operating lease liability, net of current | 108,290 | |||
| Research and development funding liability | 18,000 | |||
| Total liabilities | 221,865 | |||
| Common stock, par value of 0.00001 per share 775,000,000 shares authorized 180,514,014 and 131,160,842 shares issued and outstanding as of december31, 2025 and 2024, respectively | 2 | |||
| Additional paid-in capital | 1,009,138 | |||
| Accumulated other comprehensive income | 82 | |||
| Accumulated deficit | -888,354 | |||
| Total stockholders equity | 120,868 | |||
| Total liabilities and stockholders equity | 342,733 | |||
Prime Medicine, Inc. (PRME)
Prime Medicine, Inc. (PRME)